Cardew Group is advising Integumen PLC as it makes its IPO on AIM today (April 5).
Integumen is a personal health care company which develops technologies and products for the human integumentary system – which includes the skin – to improve physical appearance, hygiene and general health. The company’s expertise, and its range of applications, broadly focus on skincare, oral care and wound care.
Shan Shan Willenbrock, managing director at Cardew Group, said: “We are delighted to be working with Integumen on its IPO and aftermarket financial and corporate communications. Integumen has assembled an impressive portfolio of products and technologies with exciting growth opportunities and forms a valued part of our growing life sciences client base.”